XOMA Royalty Holdings Acquired by Ligand Pharmaceuticals | Healthcare M&A Deal

Ligand Pharmaceuticals has completed the acquisition of XOMA Royalty Holdings, a healthcare services other business in California, for $39.00. XOMA Royalty Holdings holds royalty interests tied to healthcare assets, and Ligand Pharmaceuticals acquisitions focus on strengthening its pipeline economics through healthcare M&A. The Ligand Pharmaceuticals acquisitions add CA acquisitions exposure to royalty-based revenue streams in Emeryville, California. The merger acquisition is an announced strategic acquisition by a strategic buyer, with deal size undisclosed and deal terms filed in an SEC S-4 registration statement, subject to completion after regulatory and shareholder approvals.